HOME >> BIOLOGY >> NEWS
Insights into osteosarcoma in cats and dogs may improve palliative care

Researchers at the University of Illinois have found that a molecular pathway known to have a role in the progression of bone cancer in humans is also critical to the pathology of skeletal tumors in dogs and cats. Their work could lead to advances in the palliative care of companion animals afflicted with osteosarcoma.

The research team, which included U. of I. pathobiology professor Anne Barger, examined the homeostatic role of an enzyme, receptor activator of nuclear factor kappa-B (known as RANK), and two key modulators of its activity: RANK ligand (RANK-L) and osteoprotegrin (OPG). RANK is one of a family of receptors that regulates bone and immune homeostasis. In health, RANK, RANK-L and OPG together keep the continual process of bone growth and resorption in balance.

Bone tumors presumably derail this homeostatic process, however, by upregulating RANK-L expression. RANK-L binds to RANK, stimulating the production and activation of osteoclasts (bone cells that increase the breakdown of bone tissue).

OPG counter-regulates RANK-L by blocking its ability to bind to RANK.

Eventual therapeutic interventions may make use of OPG or other RANK-L inhibitors to slow the process of bone destruction in skeletal tumors in cats and dogs, Barger said. Although not a cure, this could reduce the pain and other complications associated with bone cancer. Such therapies have proven effective at reducing pathologic bone loss in human bone cancer patients.

The researchers are the first to verify that the expression of this protein, which worsens the effects of bone cancer in humans, also occurs in cats and dogs with skeletal tumors. Their study appears in the January-February issue of the Journal of Veterinary Internal Medicine.

"Osteosarcoma is much more common in veterinary medicine than in human medicine," Barger said. "And in dogs it is fairly common."

Other studies have reported a tenfold greater incide
'"/>

Contact: Diana Yates
diya@uiuc.edu
217-333-5802
University of Illinois at Urbana-Champaign
1-Mar-2007


Page: 1 2

Related biology news :

1. Insights into honey bee sex gene could bring sweet success in breeding
2. Insights into activity-dependent neuronal growth through RSRF-supported research
3. Symposium Environmental Change in Siberia -- Insights From Earth Observation and Modeling
4. Yale technology spins out varicose vein device company: Vascular Insights, LLC
5. New test improves detection of liver cancer
6. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
7. Gene expression pattern could lead to improved treatment of pediatric septic shock
8. Additional mammogram readers improve breast cancer detection
9. New role for protein in fat cells may improve understanding of obesity and diabetes
10. Jefferson scientists patent dramatically improves
11. Cardiac patches stimulate regeneration, improve function after heart attack

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/30/2019)... ... September 30, 2019 , ... ... organization focused on molecular manufacturing and other transformative technologies, announced the 2018 ... College graduate or undergraduate student whose work is considered most notable in ...
(Date:9/24/2019)... ... September 23, 2019 , ... ... Cambridge, MA, announce today that Holotype HLA and other Omixon products will be ... the American Society for Histocompatibility and Immunogenetics (ASHI) in Pittsburgh, PA. ...
(Date:9/17/2019)... ... 17, 2019 , ... VISTAAR released ADVISORY Playbooks to help small ... / 2nd opinion to their internal strategies they formed for developing or launching new ... new markets, or planning to change their product elements and want to know the ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... ... October 10, 2019 , ... VirTrial today ... centers in Europe. All Pratia research centers have completed VirTrial’s Virtual Trial Capable ... certified as Virtual Trial Capable and prepared to conduct decentralized clinical trials (DCT). ...
(Date:10/8/2019)... ... ... Today, Massachusetts stem cell biotechnology company Asymmetrex announces the recent patenting in ... in the U.S. in 2017, the new patent covers the company’s unique technology for ... in the U.S. as the AlphaSTEM Test™. The new patent will support marketing ...
(Date:10/3/2019)... ... 2019 , ... Today marked the official launch of ... outsourcing success by cultivating radical improvements in leadership, staff, and broader project team ... phaseUP™ brings clients deep, broad and unique expertise in the intricacies of drug ...
(Date:10/3/2019)... ... October 02, 2019 , ... Rapid Novor, Inc., the world's ... it has moved into a new, 5000 sqft, purpose-built, state-of-the-art facility. Now home ... the company's continuous commitment to quality research and service offerings. , ...
Breaking Biology Technology:
Cached News: